AMALY — SHARIAH COMPLIANCE REPORT
==================================
Symbol: BDRX
Report Date: 2026-04-02
Full Report: https://amaly.io/stock/BDRX

EXECUTIVE SUMMARY
------------------
Compliance Status: NON_COMPLIANT
Quality Rating: B
Description: BDRX, operating in an unknown industry, demonstrates strong performance in debt and liquidity ratios but fails critical Shariah screening due to an exceptionally high interest income ratio of 138.85%, far exceeding the 5% threshold across all standards. Business activities in biopharmaceuticals are permissible, with no non-compliant revenue identified. However, exclusion from all major Shariah indices confirms non-compliance status. Investors should note the need for full purification of any dividends received.

Primary Compliance Concerns:
- Interest income ratio of 138.85% exceeds 5% threshold, indicating significant riba exposure
- High purification requirement due to impure income dominance

Purification Requirement: 138.85%
Index Inclusion: Excluded from S&P Dow Jones Shariah Indices, MSCI Islamic Indices, FTSE Shariah Indices, and Dow Jones Islamic Market (DJIM)

KEY FINANCIAL METRICS
----------------------
Debt Ratio: 0.0%
Liquidity Ratio: 0.0%
Interest Income Ratio: 1.4%
Purification Required: 0.00%

INDEX INCLUSION STATUS
-----------------------
S&P Shariah: EXCLUDED
MSCI Islamic: EXCLUDED
DJIM: EXCLUDED
FTSE Shariah: EXCLUDED
Total: 0 of 4
Last Verified: 2026-01-31

REPORTING PERIOD
-----------------
Latest Annual Report: FY 2025
Latest Quarterly Data: Q4 2025
Trend Period: FY 2020 to FY 2025
Data Retrieved: 2026-02-20T12:00:00Z

---
Full interactive report: https://amaly.io/stock/BDRX
Provided by Amaly (https://amaly.io) — Shariah Compliant Stock Screener
Disclaimer: This data is for informational purposes only and does not constitute financial or religious advice.